IGC Pharma Inc (AMEX: IGC) kicked off on Tuesday, up 3.25% from the previous trading day, before settling in for the closing price of $0.43. Over the past 52 weeks, IGC has traded in a range of $0.25-$0.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 12.85%. While this was happening, its average annual earnings per share was recorded 11.11%. With a float of $66.30 million, this company’s outstanding shares have now reached $84.14 million.
IGC Pharma Inc (IGC) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of IGC Pharma Inc is 26.99%, while institutional ownership is 3.35%. The most recent insider transaction that took place on Sep 25 ’24, was worth 200,000. In this transaction Director of this company bought 588,235 shares at a rate of $0.34, taking the stock ownership to the 942,402 shares.
IGC Pharma Inc (IGC) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.02 earnings per share (EPS), higher than consensus estimate (set at -0.03) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
IGC Pharma Inc (AMEX: IGC) Trading Performance Indicators
Take a look at IGC Pharma Inc’s (IGC) current performance indicators. Last quarter, stock had a quick ratio of 0.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 30.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.08, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.08 in one year’s time.
Technical Analysis of IGC Pharma Inc (IGC)
Looking closely at IGC Pharma Inc (AMEX: IGC), its last 5-days average volume was 3.65 million, which is a jump from its year-to-date volume of 1.31 million. As of the previous 9 days, the stock’s Stochastic %D was 58.22%.
During the past 100 days, IGC Pharma Inc’s (IGC) raw stochastic average was set at 77.57%, which indicates a significant increase from 66.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0302 in the past 14 days, which was higher than the 0.0212 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3575, while its 200-day Moving Average is $0.3301. However, in the short run, IGC Pharma Inc’s stock first resistance to watch stands at $0.4533. Second resistance stands at $0.4617. The third major resistance level sits at $0.4683. If the price goes on to break the first support level at $0.4383, it is likely to go to the next support level at $0.4317. Should the price break the second support level, the third support level stands at $0.4233.
IGC Pharma Inc (AMEX: IGC) Key Stats
The company with the Market Capitalisation of 40.41 million has total of 90,809K Shares Outstanding. Its annual sales at the moment are 1,270 K in contrast with the sum of -7,120 K annual income. Company’s last quarter sales were recorded 330 K and last quarter income was -1,600 K.
